KEY FEATURES
Full Name | Cluster Of Differentiation 160 |
---|---|
Synonym | BY55; NK1; NK28; CD160 Antigen; Natural killer cell receptor BY55 |
Assay Type | Sandwich |
Reactivity | Human |
Range | 78-5000pg/mL |
Sensitivity | 33pg/mL |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 100μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected Human CD160 in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human CD160. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human CD160 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human CD160, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human CD160. You can calculate the concentration of Human CD160 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human CD160 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (pg/mL) | 277.29 | 620.4 | 1764.02 | 268.19 | 573.57 | 1853.49 |
Standard deviation | 18.11 | 25.44 | 56.98 | 14.32 | 29.08 | 93.6 |
CV(%) | 6.53 | 4.1 | 3.23 | 5.34 | 5.07 | 5.05 |
RECOVERY
The recovery of Human CD160 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 85-96 | 91 |
EDTA plasma (n=8) | 89-104 | 97 |
Cell culture media (n=8) | 86-96 | 91 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human CD160 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with CD160 ELISA Kits
BTLA ELISA Kit | publications with CD160 and BTLA |
TNFRSF14 ELISA Kit | publications with CD160 and TNFRSF14 |
TNFSF14 ELISA Kit | publications with CD160 and TNFSF14 |
KLRD1 ELISA Kit | publications with CD160 and KLRD1 |
HLA-A ELISA Kit | publications with CD160 and HLA-A |
LCK ELISA Kit | publications with CD160 and LCK |
HLA-Cw* ELISA Kit | publications with CD160 and HLA-Cw* |
Pathways associated with CD160 ELISA Kit
Adaptive Immune System Pathway | Adaptive Immune System Pathway |
Immune System Pathway | Immune System Pathway |
Immunoregulatory Interactions Between A Lymphoid And A Non-Lymphoid Cell Pathway | Immunoregulatory Interactions Between A Lymphoid And A Non-Lymphoid Cell Pathway |
Diseases associated with CD160 ELISA Kit
Necrosis | publications with CD160 and Necrosis |
Immune System Diseases | publications with CD160 and Immune System Diseases |
Death | publications with CD160 and Death |
Inflammation | publications with CD160 and Inflammation |
Immunologic Deficiency Syndromes | publications with CD160 and Immunologic Deficiency Syndromes |
Liver Diseases | publications with CD160 and Liver Diseases |
Eye Diseases | publications with CD160 and Eye Diseases |
Metaplasia | publications with CD160 and Metaplasia |
Bone Diseases | publications with CD160 and Bone Diseases |
Organs/Tissues associated with CD160 ELISA Kit
Lung | publications with CD160 and Lung |
Kidney | publications with CD160 and Kidney |
Liver | publications with CD160 and Liver |
Embryonic Tissue | publications with CD160 and Embryonic Tissue |
Brain | publications with CD160 and Brain |